BioSpace News Archive

Press Releases

Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months

February 12, 2025
·
13 min read
Press Releases

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

February 12, 2025
·
3 min read
Press Releases

Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results

February 12, 2025
·
19 min read
Press Releases

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting

February 12, 2025
·
10 min read
Press Releases

Aligos Therapeutics Announces $105 Million Private Placement Financing

February 12, 2025
·
5 min read
Press Releases

Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

February 12, 2025
·
7 min read
Press Releases

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

February 12, 2025
·
7 min read
Press Releases

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa’s FAP Drug Receives FDA Fast Track Status

February 12, 2025
·
5 min read
Press Releases

MYND Life Sciences Announces Shares for Debt Transaction

February 12, 2025
·
2 min read
Press Releases

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

February 12, 2025
·
3 min read